Cargando…

Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy

Esophageal cancer (EC) is a complex gastrointestinal malignancy and its global incidence rate ranks 7th among all cancer types. Due to its aggressive nature and the potential for early metastasis, the survival rates of patients with EC are poor. Dihydroartemisinin (DHA) is the primary active derivat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiao, He, Lan-Ying, Lai, Shu, He, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439151/ https://www.ncbi.nlm.nih.gov/pubmed/32831913 http://dx.doi.org/10.3892/ol.2020.11955

Ejemplares similares

Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin
por: Ma, Qiang, et al.
Publicado: (2020)

Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo
por: Jiang, Cailing, et al.
Publicado: (2018)

Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy
por: Zou, Jiang, et al.
Publicado: (2019)

Dihydroartemisinin Inhibits TGF-β-Induced Fibrosis in Human Tenon Fibroblasts via Inducing Autophagy
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
por: Cui, Wei, et al.
Publicado: (2020)

Dihydroartemisinin inhibits catabolism in rat chondrocytes by activating autophagy via inhibition of the NF-κB pathway
por: Jiang, Li-Bo, et al.
Publicado: (2016)

Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
por: Rao, Qi, et al.
Publicado: (2022)

Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway
por: Liu, Yanmei, et al.
Publicado: (2018)

Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
por: Zhang, Bo, et al.
Publicado: (2021)

The activation of c-Jun NH(2)-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells
por: Jia, Guang, et al.
Publicado: (2014)

Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis
por: Zhang, Zili, et al.
Publicado: (2017)

Nanostructured Dihydroartemisinin Plus Epirubicin Liposomes Enhance Treatment Efficacy of Breast Cancer by Inducing Autophagy and Apoptosis
por: Hu, Ying-Jie, et al.
Publicado: (2018)

Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication
por: Luo, Jun, et al.
Publicado: (2021)

Dihydroartemisinin Induces Endothelial Cell Autophagy through Suppression of the Akt/mTOR Pathway
por: Liu, Jing, et al.
Publicado: (2019)

Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX
por: Chang, Jiang, et al.
Publicado: (2023)

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
por: Li, Qingrong, et al.
Publicado: (2021)

Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
por: Zhu, Lili, et al.
Publicado: (2020)

Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells
por: Wang, Yan-Yang, et al.
Publicado: (2015)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity
por: Wang, Zeng, et al.
Publicado: (2012)

Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts
por: Feng, Ming-Xuan, et al.
Publicado: (2016)

Dihydroartemisinin suppresses bladder cancer cell invasion and migration by regulating KDM3A and p21
por: Wang, Tao, et al.
Publicado: (2020)

Corrigendum: Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast cancer cells and osteoclasts
por: Feng, Ming-Xuan, et al.
Publicado: (2018)

Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2017)

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2022)

Inhibition of bromodomain-containing protein 4 enhances the migration of esophageal squamous cell carcinoma cells by inducing cell autophagy
por: Yang, Wen-Qian, et al.
Publicado: (2022)

Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer
por: CHEN, YONGSHUN, et al.
Publicado: (2015)

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells
por: ZHANG, SHUQUN, et al.
Publicado: (2014)

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall
por: Gu, Xiujuan, et al.
Publicado: (2021)

Dihydroartemisinin inhibits endothelial cell migration via the TGF-β1/ALK5/SMAD2 signaling pathway
por: Guo, Ling, et al.
Publicado: (2021)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells
por: Shao, Ying-Ying, et al.
Publicado: (2017)

Effect of LDHA Inhibition on TNF-α-Induced Cell Migration in Esophageal Cancers
por: Forkasiewicz, Agata, et al.
Publicado: (2022)

Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
por: Chen, Tao, et al.
Publicado: (2009)

Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
por: Xie, Yifei, et al.
Publicado: (2020)

Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy
por: Long, Dingde, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo
por: Zhang, Chris Zhiyi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2g7fcp6gf71aj8ve89ligg55ds